Get the Stockscreener App
0.6653
2.00%
-0.0136
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.6653, with a volume of 3.27M.
It is down -2.00% in the last 24 hours and up +14.87% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.6789
Open:
$0.71
24h Volume:
3.27M
Relative Volume:
0.33
Market Cap:
$76.55M
Revenue:
-
Net Income/Loss:
$-27.11M
P/E Ratio:
-1.0235
EPS:
-0.65
Net Cash Flow:
$-26.55M
1W Performance:
+7.99%
1M Performance:
+14.87%
6M Performance:
-14.71%
1Y Performance:
-75.98%
1-Day Range:
$0.65
$0.715
1-Week Range:
$0.601
$0.77
52-Week Range:
$0.2522
$2.95
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.6653 | 78.11M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-29-25 | Initiated | Chardan Capital Markets | Buy |
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
683 Capital Management LLC Makes New Investment in Reviva Pharmaceuticals Holdings, Inc. $RVPH - Defense World
Reviva Pharmaceuticals (RVPH) Stock Today: Price, News, Forecast & Schizophrenia NDA Setup – 10 December 2025 - ts2.tech
Stock Traders Purchase Large Volume of Call Options on Reviva Pharmaceuticals (NASDAQ:RVPH) - Defense World
Reviva Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:RVPH) - MarketBeat
Dhariwal Corp Limited Chart Enters High Volatility ZoneHigh Beta Stocks & Maximize ROI With Proven Growth Stocks - earlytimes.in
Published on: 2025-12-06 19:16:30 - moha.gov.vn
How supply chain issues affect Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockWeekly Investment Summary & Accurate Buy Signal Alerts - Newser
Largest borrow rate increases among liquid names - TipRanks
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Are Smart Investors Making the Right Decision? Reviva Pharmaceuticals Holdings Inc (RVPH) - setenews.com
Is RVPH Positioned For NDA Submission In Schizophrenia By 2026? - RTTNews
Reviva’s Schizophrenia Bet Pits Huge Upside Against Harsh Risks - Finimize
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock maintain growth trajectory2025 Trading Recap & AI Forecasted Entry and Exit Points - BỘ NỘI VỤ
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
EBIT per share of Reviva Pharmaceuticals Holdings, Inc. Warrant 2020- 25.12.25 on Reviva Pharm – NASDAQ:RVPHW - TradingView
RVPH: Brilaroxazine Poster Presentations - Yahoo Finance
Brokers Offer Predictions for RVPH FY2025 Earnings - MarketBeat
Reviva Pharmaceuticals Holdings, Inc. Warrant 2020- 25.12.25 on Reviva Pharm - TradingView
How currency fluctuations impact Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockLayoff News & Real-Time Volume Analysis Alerts - newser.com
Analysts Conflicted on These Consumer Goods Names: Clene (CLNN) and Target (TGT) - The Globe and Mail
Reviva Pharmaceuticals Holdings (RVPH) Price Target Increased by 34.17% to 5.86 - MSN
Is Reviva Pharmaceuticals Holdings Inc. forming a bottoming baseChart Signals & Stepwise Swing Trade Plans - newser.com
Why Reviva Pharmaceuticals Holdings Inc. stock is popular among millennialsTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs after earnings2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com
Full technical analysis of Reviva Pharmaceuticals Holdings Inc. Equity Warrant stockTrade Entry Report & Weekly Momentum Picks - newser.com
Free cash flow per share of Reviva Pharmaceuticals Holdings, Inc. Warrant 2020- 25.12.25 on Reviva - TradingView
Order flow analysis tools used on Reviva Pharmaceuticals Holdings Inc. Equity WarrantWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock dividend yield sustainableMarket Activity Report & Low Risk Growth Stock Ideas - newser.com
MSN Money - MSN
Best data tools to analyze Reviva Pharmaceuticals Holdings Inc. stock2025 Volume Leaders & Long-Term Capital Growth Ideas - newser.com
Is Reviva Pharmaceuticals Holdings Inc. stock positioned for digital transformationQuarterly Risk Review & AI Based Buy and Sell Signals - newser.com
Price momentum metrics for Reviva Pharmaceuticals Holdings Inc. Equity Warrant explainedLayoff News & Weekly Top Stock Performers List - newser.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Key resistance and support levels for Reviva Pharmaceuticals Holdings Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
Reviva Pharmaceuticals Holdings options imply 21.1% move in share price post-earnings - MSN
What indicators show strength in Reviva Pharmaceuticals Holdings Inc. Equity WarrantMarket Movement Recap & AI Driven Price Forecasts - newser.com
Forecasting Reviva Pharmaceuticals Holdings Inc. Equity Warrant price range with options data2025 Performance Recap & Technical Entry and Exit Alerts - newser.com
Reviva Pharmaceuticals reports Q3 EPS (6c), consensus (10c) - MSN
Price action breakdown for Reviva Pharmaceuticals Holdings Inc. Equity Warrant - newser.com
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):